- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03952000
Influence of Prior Walking on Postprandial Metabolism in Centrally Obese Men
Influence of Prior Walking on Endothelial Function and Coronary Heart Disease Risk Markers in Centrally Obese South Asian and White European Men
The present study will investigate the effect of prior walking on postprandial metabolism and endothelial function in centrally obese South Asian and White European men.
Participants will complete two, 2-day trials in a random, crossover design separated by at least a week.
On day 1, participants will either rest or complete a 60 minute walk at 60% maximal oxygen uptake. On day 2, participants will arrive at 08:00 having fasted overnight and a baseline venous blood sample and endothelial function measurement will be taken. Participants will consume a high-fat breakfast and lunch and 12 subsequent venous blood samples will be taken throughout the day at standardised intervals to measure a variety of coronary heart disease risk markers. A second endothelial function measurement will be completed 2 hours after the breakfast. Blood pressure will be measured every hour.
It is expected that the South Asian participants will have impaired metabolism and endothelial function compared to their European counterparts but the bout of exercise performed on day 1 will mitigate these responses.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
South Asians have a higher-than-average risk of coronary heart disease. The reasons for this are unclear, but physical inactivity and/or poor responsiveness to exercise may play a role. It is important to understand the effect of exercise on endothelial function and coronary heart disease risk markers in the hope that exercise can be prescribed as an effective treatment to mitigate endothelial dysfunction and the risk of heart disease.
Previous research from the investigators' laboratory has indicated that postprandial metabolism is impaired in South Asian men, but this, and other coronary heart disease risk markers, can be improved with acute exercise. However, the previous research was conducted in apparently healthy South Asian and White European men. The investigators now wish to quantify and compare the coronary heart disease risk marker and endothelial function response to acute exercise in centrally obese South Asian and White European individuals who are at a higher risk for diabetes and cardiovascular disease.
On visit 1, participants will attend the laboratory to undergo preliminary assessments and to be familiarised with the laboratory environment and study procedures. Specifically, health status, habitual physical activity, dietary habits and anthropometric data (height, weight, waist and hip circumference, body fat) will be collected. A HbA1c test will be performed to check participants are not diabetic. The modified Bruce Treadmill test will be performed to predict maximal oxygen uptake.
On visit 2, participants will undergo a magnetic resonance imaging (MRI) scan to quantify regional body composition comprising abdominal subcutaneous adipose tissue, visceral adipose tissue, liver fat percentage, thigh intramuscular adipose tissue and thigh muscle volume.
On visits 3-6 participants will complete two, 2-day trials in a random, crossover design separated by at least 1 week. On day 1 of both trials, participants will arrive fasted at 08:00 and a baseline blood sample, blood pressure and endothelial function measurement will be taken. Participants will consume a standardised high fat breakfast at 09:00 and lunch at 13:00. At 15:30 the participants will walk for 60 minutes at 60% maximal oxygen uptake and complete a second endothelial function measurement at 16:45. Participants will leave the laboratory with a standardised evening meal to consume before 22:00. The control trial will be the same, except no exercise will be performed.
On day 2, participants will arrive at 08:00 having fasted overnight for 10h (except plain water). A cannula will be inserted into the antecubital vein for collection of venous blood samples. Blood pressure will be measured at 08:00 (0h) and again at hourly intervals throughout the day. Endothelial function will measured at 08:15 (0.25h) and again at 3h. At 0h, a fasting blood sample will be collected. Subsequent venous blood samples will be collected at 1.5, 1.75, 2, 3, 4, 5, 5.5, 5.75, 6, 7, 8 and 9h. Participants will consume a standardised high fat breakfast at 1h and a standardised high fat lunch at 5h. The meals consist of 57% fat, 32% carbohydrate and 11% protein. The meals provide 14.3 kcal per kg of body mass.
Participants will rest in the laboratory throughout day 2 of both the exercise and control trials.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Loughborough, Royaume-Uni, LE11 3TU
- National Centre for Sport and Exercise Medicine, Loughborough University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- 18 to 60 year old South Asian and White European men;
- Centrally obese (waist circumference >90cm for South Asians, >94cm for White Europeans);
- Weight stable for the past 3 months;
- Non-smokers;
- No known contradictions to maximal exertion exercise.
Exclusion Criteria:
- Musculoskeletal injury that has affected normal ambulation within the last month;
- Congenital heart disease;
- Any muscle or bone injuries that do not allow them to walk on a treadmill;
- Uncontrolled exercise-induced asthma;
- Coagulation or bleeding disorders;
- Diabetes (metabolism will be different to non-diabetics potentially skewing the data);
- Taking any medication that might influence fat metabolism;
- Taking any medication that might influence blood glucose (e.g., insulin for diabetes);
- Heart conditions;
- Smoking;
- Dieting or restrained eating behaviours;
- Weight fluctuation greater than 3 kg in the previous 3 months to study enrolment;
- A food allergy.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Experimental: Exercise
Exercise: Participants will walk for 60 minutes at 60% maximal oxygen uptake on day 1.
|
Une marche de 60 minutes à 60% de consommation maximale d'oxygène.
|
Aucune intervention: No Intervention: Control
Participants will rest on day 1.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Triacylglycerol changes in response to exercise and feeding
Délai: Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
|
Fasting on day 1 and 2. Time-course of plasma triacylglycerol concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
|
Endothelial function changes in response to exercise and feeding
Délai: Day 1 fasting and 8.75hours. Day 2 fasting and 2.5hours.
|
Changes in endothelial function via flow-mediated dilatation in response to feeding and exercise.
|
Day 1 fasting and 8.75hours. Day 2 fasting and 2.5hours.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Cholestérol total
Délai: Jeûne du jour 1. Jeûne du jour 2.
|
Cholestérol total plasmatique à jeun aux jours 1 et 2 des deux essais.
|
Jeûne du jour 1. Jeûne du jour 2.
|
Cholestérol à lipoprotéines de haute densité
Délai: Jeûne du jour 1. Jeûne du jour 2.
|
Cholestérol à lipoprotéines de haute densité à jeun aux jours 1 et 2 des deux essais.
|
Jeûne du jour 1. Jeûne du jour 2.
|
Cholestérol à lipoprotéines de basse densité
Délai: Jeûne du jour 1. Jeûne du jour 2.
|
Cholestérol à lipoprotéines de basse densité à jeun aux jours 1 et 2 des deux essais.
|
Jeûne du jour 1. Jeûne du jour 2.
|
Glucose changes in response to exercise and/or feeding
Délai: Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
|
Fasting on day 1 and 2. Time-course of plasma glucose concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 1.75hours, 2hours, 3hours, 4hours, 5hours, 5.5hours, 5.75hours, 6hours, 7hours, 8hours and 9hours.
|
Blood pressure changes in response to exercise and/or feeding
Délai: Day 1 fasting. Day 2 fasting (0 hour point) and 1hours, 2hours, 3hours, 4hours, 5hours, 6hours, 7hours, 8hours and 9hours.
|
Changes in blood pressure (systolic and diastolic).
|
Day 1 fasting. Day 2 fasting (0 hour point) and 1hours, 2hours, 3hours, 4hours, 5hours, 6hours, 7hours, 8hours and 9hours.
|
Insulin changes in response to exercise and/or feeding
Délai: Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 2hours, 4hours, 5hours, 5.5hours, 7hours, 8hours.
|
Fasting on day 1 and 2. Time-course of plasma insulin concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 2hours, 4hours, 5hours, 5.5hours, 7hours, 8hours.
|
Non-esterified fatty acids changes in response to exercise and/or feeding
Délai: Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 2hours, 4hours, 5hours, 5.5hours, 7hours and 9hours.
|
Fasting on day 1 and 2. Time-course of plasma non-esterified fatty acid concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 1.5hours, 2hours, 4hours, 5hours, 5.5hours, 7hours and 9hours.
|
Interleukin-6 changes in response to exercise and/or feeding
Délai: Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Fasting on day 1 and 2. Time-course of plasma interleukin-6 concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
C-Reactive protein changes in response to exercise and/or feeding
Délai: Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Fasting on day 1 and 2. Time-course of plasma C-Reactive protein concentrations in response to exercise and/or feeding on day 2.
|
Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Tumor Necrosis Factor concentrations
Délai: Day 1 fasting. Day 2 fasting.
|
Fasting tumor necrosis factor on day 1 and 2 of both trials.
|
Day 1 fasting. Day 2 fasting.
|
Peroxiredoxin-4 changes in response to exercise and/or feeding
Délai: Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Fasting on day 1 and 2. Time-course of plasma peroxiredoxin-4 concentrations across day 2 of both trials.
|
Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Superoxide dismutase 3
Délai: Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Fasting on day 1 and 2. Time-course of plasma Superoxide dismutase 3 concentrations across day 2 of both trials
|
Day 1 fasting. Day 2 fasting (0 hour point), 3hours, 6hours and 8hours.
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Publications et liens utiles
Publications générales
- Arjunan SP, Deighton K, Bishop NC, King J, Reischak-Oliveira A, Rogan A, Sedgwick M, Thackray AE, Webb D, Stensel DJ. The effect of prior walking on coronary heart disease risk markers in South Asian and European men. Eur J Appl Physiol. 2015 Dec;115(12):2641-51. doi: 10.1007/s00421-015-3269-7. Epub 2015 Oct 5.
- Arjunan SP, Bishop NC, Reischak-Oliveira A, Stensel DJ. Exercise and coronary heart disease risk markers in South Asian and European men. Med Sci Sports Exerc. 2013 Jul;45(7):1261-8. doi: 10.1249/MSS.0b013e3182853ecf.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- R18-P120
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .